DCF — TEXAS HEALTH DENTON
Enterprise Value: $38.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$38.1M
Enterprise Value
$4.3M
PV of Cash Flows
$33.8M
PV of Terminal Value
$54.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $275.7M | $10.4M | 4.0% | $-2.1M | $-2.0M |
| Year 2 | $284.0M | $13.6M | 5.0% | $-0.1M | $-0.1M |
| Year 3 | $292.5M | $16.9M | 6.0% | $2.1M | $1.6M |
| Year 4 | $301.3M | $18.9M | 6.0% | $3.3M | $2.3M |
| Year 5 | $310.4M | $20.2M | 7.0% | $4.0M | $2.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $38.1M. Terminal value accounts for 89% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$267.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.03271269780817345
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5